𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomized Clinical Trials in Hepatocellular Carcinoma

✍ Scribed by Yopp, Adam C.; Jarnagin, William R.

Book ID
123540932
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
99 KB
Volume
19
Category
Article
ISSN
1055-3207

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A meta-analysis of survival rates of unt
A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma
✍ Giuseppe Cabibbo; Marco Enea; Massimo Attanasio; Jordi Bruix; Antonio CraxΓ¬; Cal πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 406 KB

Knowing the spontaneous outcome of hepatocellular carcinoma (HCC) is important for designing randomized controlled trials (RCTs) of new therapeutic approaches; however, survival of patients in the absence of treatment is highly variable, and prognostic factors influencing outcomes are incompletely d

A randomized multicenter phase II clinic
A randomized multicenter phase II clinical trial of mitoxantrone-loaded nanoparticles in the treatment of 108 patients with unresected hepatocellular carcinoma
✍ Qinghua Zhou; Xun Sun; Lingyuan Zeng; Jie Liu; Zhirong Zhang πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 151 KB

## From the clinical editor: Intravenous administration of mitoxantrone-loaded polybutylcyanacrylate nanoparticles (dhad-pbca-nps) allows increased cytotoxicity in hepatic tumors and prolonged the median survival periods to 5.46 months compared to 3.23 months in controls.